Follow-on biologic drug competition – No need for new marketing exclusivities

Issue  JCB, Volume 16, Number 1, 2010  Commentary 

Michael S Wroblewski
Elizabeth A Jex

DOI:https://doi.org/10.5912/jcb313


Abstract:

 

 

Keywords:en ,

Download PDF